The different survival properties of CD44v6 cells in vitro and in established tumours are likely due to the protective activity of the tumour microenvironment.31 Outside the protective tumour context, PI3K and AKT inhibitors can kill CR-CSCs. Here, PIK3CA is linked to neoplasm.